A New York State opioid trial has been set for January. The trial would be the second state-level case focused on the opioid crisis. It was brought by Nassau and Suffolk counties against a group of drug manufacturers and distributors. (Associated Press)

Juul has stopped sales of its mint-flavored pods in the U.S. The news came after a report released this week found that mint is the preferred flavor for teens. Juul will now only sell tobacco and menthol flavors. (Reuters)

Vaping lung illness cases have risen to 2,051 and 39 deaths, according to data from the Centers for Disease Control and Prevention. The CDC’s investigation is ongoing. Two health officials from the CDC and the Center for Tobacco Products are set to testify before Congress next week. (CNBC)

The Trump administration has sued Gilead over an HIV prevention drug patent. The lawsuit said that the government owns the patent for Truvada and Descovy, Gilead’s PrEP drugs, and that government researchers began studying the compound before Gilead filed for its patent. (NBC News)

Pharma supplier Fagron will pay $22.5 million over inflated drug prices. The Justice Department has said the company and its subsidiaries inflated average prices for compound drug ingredients and submitted fraudulent claims to federal healthcare programs. (Reuters)